JOYCE WALL: Open Payments
NPI 1457949000 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,453 in 114 payments from 14 companies in 2025. Trend: 2023 $1,026 · 2024 $1,399 · 2025 $2,453
Food & beverage: $2,453
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $701 |
| Otsuka America Pharmaceutical, Inc. | 19 | $444 |
| ABBVIE INC. | 23 | $382 |
| GlaxoSmithKline, LLC. | 13 | $228 |
| Novo Nordisk Inc | 7 | $183 |
| Axsome Therapeutics, Inc. | 4 | $112 |
| Amgen Inc. | 4 | $102 |
| Lundbeck LLC | 4 | $90 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
Products named: REXULTI, FARXIGA, VRAYLAR, BREZTRI, TRELEGY ELLIPTA, Auvelity, OTEZLA, Wegovy.
Industry payments across CT — which companies pay providers there.
